BlackRock Capital Allocation Trust (BCAT) is a strategically managed investment vehicle tailored for institutional investors, featuring a diversified portfolio that spans global equities and fixed-income markets. Leveraging BlackRock's extensive market insights and research capabilities, BCAT employs a dynamic investment strategy designed to optimize capital allocation across various asset classes, allowing for agile responses to changing market conditions. This strategic flexibility positions the trust to deliver sustainable income and long-term capital appreciation, making it an appealing option for investors seeking to enhance risk-adjusted returns and achieve comprehensive portfolio diversification.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | 0.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | — |
| Price-to-Book | 0.94 |
| Price-to-Sales (TTM) | 5.84 |
| EV/Revenue | 5.84 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $105.84M |
| Float | 0 |
| % Insiders | 0.01% |
| % Institutions | 18.44% |
Volatility is currently contracting
BlackRock Capital Allocation Term Trust announced a rights offering with a conservative 1-for-5 ratio and a 98.5% NAV floor. The subscription price is set at 95% of market price, capped at $0.01 below NAV, minimizing dilution to a worst-case ~-0.25%. BCAT's premium compressed sharply post-announcement, highlighting the risk of holding CEFs at elevated premiums ahead of offerings.
A year ago, the Guggenheim Strategic Opportunity fund (GOF) was on top of the CEF world, trading at a 30% market price premium over its NAV. But there was another equity/fixed-income CEF coming up on its heels and once the BlackRock Capital Allocation fund (BCAT) got a 124% distribution raise in 2024, it was off to-the-races. The result has been one of the most diverging fortunes for both funds that I have ever seen in CEFs.
BlackRock Capital Allocation Term Trust remains a hold, with its high yield supported by recent tech-driven rallies but unsustainable over the long term. BCAT's option writing and concentrated portfolio have fueled outperformance, but these strategies cap long-term growth and risk NAV erosion as payouts exceed earnings. Current distributions are largely return of capital, with 91% YTD, signaling NAV drawdown and limited sustainability if market momentum fades or interest rates rise.
NEW YORK--(BUSINESS WIRE)--BlackRock Provides Update on Closed-End Fund Discount Management Programs.
The BlackRock Capital Allocation Term Trust (BCAT) offers a nearly 20% managed distribution rate, but that payout creates real pressure on NAV unless portfolio returns remain strong. The fund is higher quality than many ultra-high-yield peers because it is diversified, unlevered, and not built around a single-stock option strategy. The main concern is not ROC classification alone, but the combination of heavy ROC, weak price appreciation, recurring payout step-downs, and NAV erosion.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on BCAT and any ticker you trade — then tracks every position and per-strategy win rate.
